Elanco Animal Health (ELAN) is down 7.7% today. Here is some analysis on what might have caused this price movement. ([investor.elanco.com](https://investor.elanco.com/node/14761/html))
Analysis: The most likely explanation is a sell-the-news reaction after investors digested Elanco’s August 5, 2026 earnings release. The company posted strong second-quarter results and raised its full-year outlook, so today’s drop appears more consistent with profit-taking and a reset in expectations than with a clearly negative fundamental update. ([investor.elanco.com](https://investor.elanco.com/node/14761/html))
Details:
Sources:
Elanco Animal Health, SEC, MarketBeat
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$ELAN Insider Trading Activity
$ELAN insiders have traded $ELAN stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ELAN stock by insiders over the last 6 months:
- RAJEEV A. MODI (SEE REMARKS) purchased 4,911 shares for an estimated $99,938
- JEFFREY N SIMMONS (PRESIDENT, CEO AND DIRECTOR) purchased 4,971 shares for an estimated $99,842
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ELAN Hedge Fund Activity
We have seen 232 institutional investors add shares of $ELAN stock to their portfolio, and 253 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WINSLOW CAPITAL MANAGEMENT, LLC added 13,614,355 shares (+inf%) to their portfolio in Q1 2026, for an estimated $318,507,835
- DODGE & COX removed 10,140,205 shares (-12.8%) from their portfolio in Q1 2026, for an estimated $237,230,095
- MILLENNIUM MANAGEMENT LLC removed 7,408,568 shares (-91.2%) from their portfolio in Q1 2026, for an estimated $173,323,448
- SEI INVESTMENTS CO added 4,975,721 shares (+737.5%) to their portfolio in Q1 2026, for an estimated $116,406,992
- NUVEEN, LLC removed 3,850,285 shares (-63.2%) from their portfolio in Q1 2026, for an estimated $90,077,417
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC added 2,871,561 shares (+inf%) to their portfolio in Q1 2026, for an estimated $67,180,169
- MORGAN STANLEY removed 1,869,081 shares (-22.6%) from their portfolio in Q1 2026, for an estimated $43,727,149
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ELAN Analyst Ratings
Wall Street analysts have issued reports on $ELAN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 05/07/2026
To track analyst ratings and price targets for $ELAN, check out Quiver Quantitative's $ELAN forecast page.
$ELAN Price Targets
Multiple analysts have issued price targets for $ELAN recently. We have seen 6 analysts offer price targets for $ELAN in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- Steve Scala from TD Cowen set a target price of $32.0 on 06/18/2026
- Chris Schott from JP Morgan set a target price of $30.0 on 05/07/2026
- Daniel Grosslight from Citigroup set a target price of $31.0 on 05/07/2026
- Erin Wright from Morgan Stanley set a target price of $24.0 on 02/25/2026
- Steve Dechert from Keybanc set a target price of $29.0 on 02/25/2026
- Daniel Clark from Leerink Partners set a target price of $30.0 on 02/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
